Read + Share
Kim YJ, Kim S, Kim TM, Suh KJ, et al. A phase II study of osimertinib in patients with NSCLC harboring EGFR exon 20
insertion: A multicenter trial of the Korean Cancer Study Group (LU17-19). Lung Cancer 2024;194:107870.
PMID: 38986212
|
 |
|
Kim YJ, Kim S, Kim TM, Suh KJ, et al. A phase II study of osimertinib in patients with NSCLC harboring EGFR exon 20
insertion: A multicenter trial of the Korean Cancer Study Group (LU17-19). Lung Cancer 2024;194:107870.
PMID: 38986212
|
|
|
|